Nerve growth factor rescue of cisplatin neurotoxicity is mediated through the high affinity receptor: Studies in PC12 cells and p75 null mouse dorsal root ganglia

Neuroscience Letters

Volumn 308, Issue 1, 2001, Pages 1-4

  Fischer, Stephanie J ^a   Podratz, Jewel L ^a   Windebank, Anthony J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Dorsal root ganglia; Nerve growth factor

Indexed keywords

CISPLATIN; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN P75; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL STRAIN; CHIMERA; CONTROLLED STUDY; EMBRYO; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NULL CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; SPINAL GANGLION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GANGLIA, SPINAL; HUMANS; MICE; MICE, KNOCKOUT; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENTS; PC12 CELLS; PERIPHERAL NERVOUS SYSTEM DISEASES; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035958820     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)01956-5     Document Type: Article

References (21)

1. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy
2. Neuro- and ototoxicity of high-dose carboplatin treatment in poor prognosis ovarian cancer patients
3. Carboplatin toxic effects on the peripheral nervous system of the rat
4. Off-treatment course of cisplatin-induced dorsal root ganglia neuronopathy in rats
5. An ultrastructural study of neuronal changes in dorsal root ganglia (DRG) of rats after chronic cisplatin administrations
6. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle
7. Nerve-growth-factor-dependent neurite outgrowth assay; a research model for chemotherapy-induced neuropathy
8. Cisplatin neurotoxicity: The relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity
9. Progressive paesthesias after cessation of therapy with very high-dose cisplatin
10. Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro
11. Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function
12. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system
13. Cisplatin-mediated apoptosis of DRG neurons is linked to the redistribution of cytosolic BAX and cytochrome c release but not to fas receptor signalling
14. High-dose cisplatin in hypertonic saline in refractory ovarian cancer
15. NTR and Fas?
16. Oxaliplatin: A review of preclinical and clinical studies
17. Peripheral sensory neuropathy and cisplatin chemotherapy
18. Chimeric tumor necrosis factor-TrkA receptors reveal that ligand-dependent activation of the TrkA tyrosine kinase is sufficient for differentiation and survival of PC12 cells
19. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies
20. Phase I trial and pharmacokinetic study of ormaplatin
21. Neurotoxic effects of cisplatin therapy